Research progress of SARS-CoV, MERS-CoV, SARS-CoV-2
-
摘要: 冠状病毒主要分为α-冠状病毒、β-冠状病毒、γ-冠状病毒和δ-冠状病毒4个类型,其中对人类致病的冠状病毒主要集中在β-冠状病毒属。21世纪以来,在人类中引起爆发流行的主要有3种:SARS-CoV,MERS-CoV和SARS-CoV-2。它们在种属进化上均与蝙蝠冠状病毒密切相关,都能造成人际间传播,可引起肺炎、急性呼吸窘迫综合征、甚至休克及器官功能衰竭,发展至重症时有较高的病死率。新型冠状病毒爆发流行,给人类健康造成不可估量的危害,还会对全球社会经济造成极大损失,是目前世界公共卫生一大难题;新型冠状病毒致病力及传染性强,目前治疗尚无特效药,主要以预防为主,需要"未雨绸缪",积极应对。本文就21世纪以来爆发流行的SARS-CoV,MERS-CoV和SARS-CoV-2新型冠状病毒的研究进展作一综述,为临床更好地防治新型冠状病毒提供新思路。Abstract: Coronaviruses are mainly divided into 4 types: α-coronavirus, β-coronavirus, γ-coronavirus and δ-coronavirus. Coronaviruses which are pathogenic to humans are mainly concentrated in the genus β-coronavirus. Since the 21st century, there have 3 main outbreaks in humans: SARS-CoV, MERS-CoV and SARS-CoV-2. They are closely related to bat coronavirus in species evolution, which can cause human-to-human transmission, pneumonia, acute respiratory distress syndrome, and even shock and organ failure. They have a higher mortality rate when they develop into severe illness. The outbreak of coronaviruses would cause immeasurable harm to human health and cause great losses to the global society and economy. It is a major problem in public health in the world at present. The new coronaviruses is highly pathogenic and infectious.The treatment is mainly prevention-oriented, with no effective medicines. This article reviews the research progress of the outbreak of coronaviruses since the 21st century, and provides new ideas for better clinical prevention and treatment of new coronaviruses.
-
Key words:
- coronavirus /
- host /
- research progress /
- new coronavirus control
-
表 1 各型人冠状病毒的特点
Table 1. Characteristics of human coronavirus
病毒亚型 发现时间(年) 类别 基因组特点 受体 主要相关疾病 SARS-CoV 2003 β-B 29.7 kb ACE2 严重急性呼吸窘迫综合征 MERS-CoV 2012 β-C 30.1 kb CD26(DPP4) 肺炎,急性呼吸窘迫综合征,急性肾衰竭 SARS-CoV-2 2019 β 29.9 kb ACE2 肺炎,急性呼吸窘迫综合征,脓毒性休克 -
[1] 黄 平, 俞守义. 人类冠状病毒与SARS-CoV[J]. 中国预防医学杂志, 2005, 6(6): 552-5. doi: 10.3969/j.issn.1009-6639.2005.06.038 [2] 王承忠, 戚正武. SARS病毒及相关冠状病毒的生物学特征[J]. 生物化学与生物物理学报, 2003, 35(6): 495-502. [3] Dignard C, Leibler JH. Recent research on occupational animal exposures and health risks: a narrative review[J]. Current environmental health reports, 2019, 6(4): 501-12. [4] Diego F, Rachele C, Clerici M, et al. Molecular evolution of human coronavirus genomes[J]. Trends Microbiol, 2017, 25(1): 35-9. doi: 10.1016/j.tim.2016.09.001 [5] 沈 军, 俞 蕙, 朱启镕. 人冠状病毒与人类呼吸道感染[J]. 中国循证儿科杂志, 2013, 8(2): 154-9. [6] Chen Y, Guo D. Molecular mechanisms of coronavirus RNA capping and methylation[J]. Virol Sin, 2016, 31(1): 3-11. doi: 10.1007/s12250-016-3726-4 [7] Lu G, Wang Q, Gao GF. Bat-to-human: spike features determining'host jump'of coronaviruses SARS-CoV, MERS-CoV, and beyond[J]. Trends Microbiol, 2015, 23(8): 468-78. doi: 10.1016/j.tim.2015.06.003 [8] Chan JW, Lau SP, To KW, et al. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-Like disease[J]. Clin Microbiol Rev, 2015, 28(2): 465-522. doi: 10.1128/CMR.00102-14 [9] Fong WI. Emerging zoonoses[M]. Germany: Springer International Publishing , 2017: 15-38. [10] Graham RL, Recombination BR. Reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission[J]. J Virol, 2010, (84): 3134-46. [11] Hilgenfeld R, Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses[J]. Antiviral Res, 2013, 100(1): 286-95. doi: 10.1016/j.antiviral.2013.08.015 [12] de Wit E, van Doremalen N, Falzarano D, et al. SARS and MERS: recent insights into emerging coronaviruses[J]. Nat Rev Microbiol, 2016, 39(14): 523-35. [13] Tan YJ, Lim SG, Hong W. Understanding the accessory viral proteins unique to the severe acute respiratory syndrome(SARS)coronavirus[J]. Antiviral Res, 2006, 72(2): 78-88. doi: 10.1016/j.antiviral.2006.05.010 [14] Fan Y, Zhao K, Shi ZL, et al. Bat coronaviruses in China[J]. Viruses, 2019, 11(3): 210-21. doi: 10.3390/v11030210 [15] 毕振强, 赵仲堂. SARS的流行病学特征[J]. 疾病控制杂志, 2004, 8(2): 148-51. doi: 10.3969/j.issn.1674-3679.2004.02.016 [16] Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome[J]. N Engl J Med, 2003, 348(20): 1967-76. doi: 10.1056/NEJMoa030747 [17] Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J]. N Engl J Med, 2012, 367(19): 1814-20. doi: 10.1056/NEJMoa1211721 [18] Cauchemez S, Nouvellet P, Cori A, et al. Unraveling the drivers of MERS-CoV transmission[J]. Proc Natl Acad Sci USA, 2016, 113(32): 9081-6. doi: 10.1073/pnas.1519235113 [19] 段昭君, 谭文杰, 鲁凤民. 中东呼吸综合征冠状病毒感染[J]. 中国病毒病杂志, 2013, 3(4): 245-9. [20] Memish ZA, Mishra N, Olival KJ, et al. Middle East respiratory syndrome coronavirus inbats, Saudi Arabia[J]. Emerg Infect Dis, 2013, 19(11): 1819-23. [21] Lu G, Hu Y, Wang Q, et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26[J]. Nature, 2013, 500(7461): 227-31. doi: 10.1038/nature12328 [22] Zhou J, Li C, Zhao G, et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus[J]. Sci Adv, 2017, 3(11): 4966-75. doi: 10.1126/sciadv.aao4966 [23] WHO. Middle East respiratory syndrome coronavirus[Z], 2018. [24] Nour R, Houssam S. Middle East respiratory syndrome coronavirus(MERS-CoV): a review[J]. Germs, 2019, 9(1): 24-35. [25] Salah T, Khamis F. Middle East respiratory syndrome coronavirus(MERS-CoV)in Oman: current situation and going forward[J]. Oman Med J, 2019, 34(3): 401-13. [26] Cho SY, Kang JM, Ha Y, et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study[J]. Lancet(London, England), 2016, 388(12): 10048-59. [27] Al-Tawfiq JA, Assiri A, Memish ZA. Middle East respiratory syndrome novel corona MERS-CoV infection.Epidemiology and outcome update[J]. Saudi Med J, 2013, 34(10): 991-4. [28] Mohd H, Memish ZA, Alfaraj SH, et al. Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia[J]. Travel Med Infect Dis, 2016, 14(5): 612-23. [29] Aleanizy FS, Mohmed N, Alqahtani FY, et al. Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study[J]. BMC Infect Dis, 2017, 17(1): 72-83. doi: 10.1186/s12879-016-2098-6 [30] Choi WS, Kang CI, Kim Y, et al. Clinical presentation and outcomes of Middle East respiratory syndrome in the republic of Korea[J]. Infect Chemoth, 2016, 48(2): 252-63. [31] Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus(MERS-CoV): a systematic review and meta-analysis[J]. International Journal of Infectious Diseases, 2016, 49(8): 1002-13. [32] Sherbini N, Iskandrani A, Kharaba A, et al. Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: demographic, clinical and survival data[J]. J Epidemiol Glob Health, 2016, 50(34): 2014-23. [33] The Who Mers-Cov Research Group. State of knowledge and data gaps of Middle East respiratory syndrome coronavirus(MERS-CoV)in humans[J]. PLoS Curr, 2013, 72(112): 3031-40. [34] Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection[J]. Ann Intern Med, 2014, 160(6): 389-97. [35] Joob B, Wiwanitkit V. Middle East respiratory syndrome coronavirus infection: a short note on cases with renal failure problem[J]. Ren Fail, 2016, 38(10): 1-2. [36] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 105(33): 503-10. [37] Woo P, Wang M, Lau S, et al. Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features[J]. J Virol, 2007, 81(4): 1574-85. doi: 10.1128/JVI.02182-06 [38] Chih-Cheng L, Tzu-Ping S, Wen-Chien K, et al. Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)and corona virus disease-2019(COVID-19): the epidemic and the challenges[J]. Int J Antimicrob Agents, 2020, 39(11): 201-13. [39] Zhou P, Yang X, Wang X, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin[J]. Bio Rxiv, 2020, 23(1): 12-7. [40] Perlman S. Another decade, another coronavirus[J]. N Engl J Med, 2020, 382(12): 215-26. [41] 中华预防医学会新型冠状病毒肺炎防控专家组. 新型冠状病毒肺炎流行病学特征的最新认识[J]. 中国病毒病杂志, 2020, 41(2): 1-7. [42] Holshue ML, Debolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States[J]. N Engl J Med, 2020, 382(10): 929-36. doi: 10.1056/NEJMoa2001191 [43] 郑 梅, 郑双丽, 陈丹瑛, 等. 蝙蝠来源的重症急性呼吸综合征样冠状病毒WIV1刺突蛋白利用浣熊狗血管紧张素转换酶Ⅱ受体侵入细胞能力的研究[J/CD]. 中华实验和临床感染病杂志: 电子版, 2019, 13(5): 370-6. [44] Chan JF, Yuan SF, Kin-Hang K, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster[J]. Lancet, 2020, 395(1223): 514-23. [45] Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020. doi:10.1038/s41586-020-2012-7. [46] Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China[J]. N Engl J Med, 2020. doi:10.1056/NEJMoa2002032. [47] 中国研究型医院学会感染与炎症放射学专业委员会, 中国性病艾滋病防治协会感染(传染病)影像工作委员会, 中华医学会放射学分会传染病学组, 等. 新型冠状病毒肺炎影像学辅助诊断指南[J/OL]. 中国医学影像技术, 2020, 36(3): 1-11. [48] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506. [49] Baharoon S, Memish ZA. MERS-CoV as an emerging respiratory illness: a review of prevention methods[J]. Travel Med Infect Dis, 2019, (32): 16-27. [50] Bleibtreu A, Bertine M, Bertin C, et al. Focus on middle east respiratory syndrome coronavirus (MERS-CoV)[J]. Méde Maladies Infect,2019,11.DOI: 10.1016/j.medmal.2019.10.004. [51] 陈 青. 成功研发出MERS病毒抗体[N]. 文汇报, 2015-06-16(007).
计量
- 文章访问数: 809
- HTML全文浏览量: 387
- PDF下载量: 15
- 被引次数: 0